Respected dementia experts and Brain+ gets EU grant to research how to optimize digital at-home treatments for people with dementia
Copenhagen, Denmark, March 14, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · The grant covers research into the two main therapeutic technologies of Brain+, digitalized Cognitive Stimulation Therapy (CST), and Computerized Cognitive Training (CCT). · The grant will also examine the hypothesized synergy effects of combining CST with CCT, which is a key research step for the third Brain+ product in the pipeline, ‘CST-for-MCI’. · University of Gothenburg is hosting the grant, which has a budget of €48,405, and is funded by the EU Joint Programme - Neurodegenerative Disease Research.